Efficacy and hypoglycaemia outcomes with once‐weekly insulin icodec versus once‐daily basal insulin in individuals with type 2 diabetes by kidney function: A post hoc participant‐level analysis of the ONWARDS 1–5 trials
Diabetes Obesity and Metabolism2025Vol. 27(4), pp. 2259–2270
Citations Over TimeTop 10% of 2025 papers
Abstract
Efficacy and hypoglycaemia outcomes of icodec versus once-daily comparators were generally consistent among adults with T2D, regardless of kidney function.
Related Papers
- → Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia(2012)1,621 cited
- → Impact of Prandial Plus Basal vs Basal Insulin on Glycemic Variability in Type 2 Diabetic Patients(2009)12 cited
- → A Simple and Rational Twice Daily Insulin Regime<subtitle>DISTINCTION BETWEEN BASAL AND MEAL INSULIN REQUIREMENTS</subtitle>(1979)33 cited
- → Maintenance of basal plasma glucose and insulin concentrations in maturity-onset diabetes(1979)28 cited
- → Combining Basal Insulin and GLP-1 Agonists Is Effective in Advanced Type 2 Diabetes(2014)